drugset
Drugs / BMMNCs
last change Jun 2026 re-read 3 minutes ago

BMMNCs

also known as Autologous Bone Marrow derived Mono Nuclear Stem Cell · autologous bone marrow-derived MNCs · Bone Marrow derived Mono Nuclear Stem Cell · bone marrow mononuclear cells · bone marrow-derived mononuclear cells

Cell therapy

Developed for
cerebellar ataxia · chronic renal failure syndrome · compartment syndrome · female infertility of uterine origin · myocardial ischemia · retinitis pigmentosa
Investigated by
Chaitanya Hospital, Pune · Ankara University · Ankara Yildirim Beyazıt University · Atigen-Cell and Tissue Center · Chinese Academy of Sciences · Dr. Sami Ulus Children's Hospital
+4 more · Hacettepe University · Oregon Health and Science University · Turkiye Yuksek Ihtisas Education and Research Hospital · Yali Hu

Trials 6

today NCT04233892 · Ph 1/2 NCT03880656 · Ph 1 NCT02323477 · Ph 1/2 NCT01876017 · Ph 1/2 NCT01958177 · Ph 1/2 NCT01914913 · Ph 1/2
2015201620172018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 11 trial
Phase 1 NCT03880656 Dec 2019 → Dec 2025 overdue compartment syndrome Oregon Health and Science University Active not recruiting No outcome recorded
Phase 1/25 trials
Phase 1/2 NCT04233892 Apr 2020 → Dec 2022 female infertility of uterine origin Yali Hu Unknown No outcome recorded
Phase 1/2 NCT02323477 Feb 2015 → Sep 2018 myocardial ischemia Ankara University Terminated No outcome recorded
Phase 1/2 NCT01876017 Sep 2014 → Nov 2016 chronic renal failure syndrome Chaitanya Hospital, Pune Unknown No outcome recorded
Phase 1/2 NCT01958177 Sep 2014 → Dec 2016 cerebellar ataxia Chaitanya Hospital, Pune Unknown No outcome recorded
Phase 1/2 NCT01914913 Sep 2014 → Nov 2016 retinitis pigmentosa Chaitanya Hospital, Pune Unknown No outcome recorded

Evidence & citations 8 cited values

Every value below carries the sentence it was read from. 7 sources stand behind the page.

FieldValueCited text
Known as BMMNCs “autologous bone marrow-derived mononuclear cells (BM-MNCs)” PMID 32840230 ↗ Nov 2020
5

NCT04233892 ↗

NCT03880656 ↗

NCT01914913 ↗

NCT01958177 ↗

NCT01876017 ↗
Known as Autologous Bone Marrow derived Mono Nuclear Stem Cell “Intravenous transfer of Autologous Bone Marrow derived Mono Nuclear Stem Cell (BMMNCs)” NCT01876017 ↗
Known as autologous bone marrow-derived MNCs “Autologous bone marrow-derived MNCs will be transplanted” NCT02323477 ↗
Known as Bone Marrow derived Mono Nuclear Stem Cell “Intravenous transfer of of Bone Marrow derived Mono Nuclear Stem Cell (BMMNCs)” NCT01958177 ↗
Known as bone marrow mononuclear cells “autologous bone marrow mononuclear cells (BM-MNCs)” NCT03880656 ↗
Known as bone marrow-derived mononuclear cells “autologous bone marrow-derived mononuclear cells (BM-MNCs)” PMID 32840230 ↗ Nov 2020
Modality Cell therapy “Bone Marrow derived Mono Nuclear Stem Cell” NCT01876017 ↗
Route Intravenous “Intravenous transfer of Autologous Bone Marrow derived Mono Nuclear Stem Cell (BMMNCs)” NCT01876017 ↗